2021 Annual SRNT-E Conference

Dr. Caillé-Garnier obtained her doctorate in Neurosciences and Neuropharmacology from the University of Bordeaux in 2000. Upon joining the CNRS in 2005, the researcher's primary focus was on the consequences of chronic drug exposure in rodents, with a particular emphasis on nicotine, opioids, and the endocannabinoid system. Subsequently, she shifted the focus of her research to the investigation of predictive factors associated with vulnerability to addictive behaviors. As a Principal Investigator (PI) or co-investigator on several university and national agency funding projects, she elucidated the role of interindividual differences, whether attributable to sex differences, cognitive or emotional profiles, in the expression of vulnerability to drug of abuse.

Beyond her academic research, Dr. Caillé-Garnier has served as a national and international expert on public health and regulatory matters. Since 2017, she has contributed as a scientific expert to ANSES (French Agency for Food, Environmental and Occupational Health & Safety) in the working group on tobacco and vaping products. Furthermore, she was a key contributor to the European "Joint Action on Tobacco Control" from 2017 to 2020, where she helped shape science-based policy recommendations. 

Luk Joossens obtained a Licence de sociology, KU Leuven, Belgium, March 1972 and Maîtrise en sociologie, Sorbonne, Paris, November 1972. Since then, for almost 50 years he has contributed to the different aspects of tobacco control, such as the eight editions of the Tobacco Control Scale (2006-2026), passive smoking, advertising, labelling, taxes, smuggling (1995-2025), tracking and tracing, tobacco industry tactics, Belgian and EU tobacco control policy, FCTC, Protocol to eliminate illicit trade in tobacco products. 

Luk Joossens worked closely together with consumer organisations (1973-2003), Europe against Cancer progamme (1988-1995), International Union against Cancer (strategic leader 2006-2009), European Cancer Leagues (1995-2020), Belgian Foundation against Cancer (2003-2016). Framework Convention Alliance (2007-2012), Smoke Free Partnership (2022-2026). He advised extensively international bodies on tobacco control such as the World Health Organization (from 1990 to 2025), the World Bank, The European Commission and the FCTC secretariat. In 2006, he received the American Cancer Society “Luther Terry Award” for Outstanding Individual Leadership in Tobacco Control and in 2015 the World Health Organization Director-General’s Special Recognition of Contribution to Global Tobacco Control.

Dr. Martínez is a senior researcher in tobacco control and implementation science. Her main areas of research include the evaluation of tobacco control policies in health care services, by assessing the impact of smoke-free policies and evaluating the effectiveness of smoking cessation and training programs. She is currently developing and testing the effectiveness of tobacco cessation training programs among healthcare professional students, and she is also evaluating policy interventions to promote smoking cessation among vulnerable persons (mentally ill or with substance abuse disorders) and promoting smoke-free environments in private settings (homes).

Dr Tessa Langley is an Associate Professor in Public Health Economics and Evaluation. She completed an Honours degree in Economics and Economic History at the University of Warwick, followed by a Master’s in Public Health at the University of Nottingham, before continuing to a research role, PhD and subsequently an academic position at the University of Nottingham. She specialises in public health economics and evaluation, with a focus on tobacco control and e‑cigarette policy. She has led numerous studies evaluating tobacco control policies in the UK and assessing the economic impact of tobacco use, highlighting how reducing smoking rates not only improves health but also helps reduce economic inequalities. In addition to her research, Dr Langley is a member of the Royal College of Physicians’ Tobacco Advisory Group, contributing to regular evidence reviews on tobacco and nicotine policy, and serves as Deputy Editor of Nicotine & Tobacco Research.